DB95.0ICD-11 MMS 2026-01
Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis
Description
This is an acute hepatocellular injury that develops within 1 to 20 weeks after starting treatment. The histological lesions consist mainly of focal, zonal or bridging necrosis, but lobular and portal tract inflammation evident with drug hepatitis. Extrahepatic features of drug hypersensitivity, including rash, lymphadenopathy, eosinophilia or other systemic features, are observed in some cases.
Index terms
- Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis
- Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis, with complications
- Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis, without complications
Exclusions from above levels
Show allHide
Sibling codes
DB95.1– Drug-induced or toxic liver disease with chronic hepatitisDB95.2– Drug-induced or toxic liver disease with cholestasisDB95.3– Drug-induced or toxic liver disease with fatty liverDB95.4– Drug-induced or toxic liver disease with granulomatous hepatitisDB95.5– Drug-induced or toxic liver disease with fibrosis or cirrhosis of liverDB95.6– Drug-induced or toxic liver disease with vascular disorders of the liverDB95.7– Drug-induced or toxic liver disease with liver tumoursDB95.Y– Other specified drug-induced or toxic liver diseaseDB95.Z– Drug-induced or toxic liver disease, unspecified
Foundation entity
Drug-induced or toxic liver disease with acute hepatic necrosis or acute hepatitis – http://id.who.int/icd/entity/1711029358
Allowed postcoordination axes
Part of: DB95: Drug-induced or toxic liver disease › 13: Diseases of the digestive system